We Turn Breakthrough Diagnostics Into National Health Impact Across Africa and the Gulf
Oasis Diagnostics, Oludent Health, and 360Disruption unite to deliver scalable saliva testing, telehealth integration, and local manufacturing —
from U.S. innovation to GCC commercialization and Africa-wide deployment.
Innovation Alone Doesn’t Change Lives — Deployment Does
Around the world, breakthrough diagnostics, telehealth, biotech, and sustainability technologies already exist. What’s missing is the ability to deploy them where they matter most — in communities that lack access, infrastructure, and investment.
360Disruption was built to close this gap.
We connect U.S. and global innovators with the GCC’s commercialization power and Africa’s urgent healthcare needs, creating a pipeline that transforms life-saving ideas into scalable national programs.
For foundations, development agencies, and impact investors, this creates a unique opportunity:
→ One platform, three continents, unlimited impact.
We bring together:
Advanced diagnostics & precision health (via Oasis Diagnostics and partner labs)
Telehealth / Teledentistry & community-level care delivery (via Oludent Health International)
FDI, job creation, and local manufacturing pathways (through 360Disruption’s GCC–Africa bridge)
This is not just innovation.
This is economic inclusion, health equity, and capacity building — delivered through partnerships that align with global development goals (SDG-3, SDG-8, SDG-9, AU Agenda 2063, Vision 2031, Vision 2030).
Foundations are essential in this ecosystem:
You enable the transition from promise to proof, from pilot to national implementation — ensuring no community is left behind in the future of healthcare.
💬 “Innovation should serve people — not the other way around.”
— Anjo de Heus, Founder of 360Disruption
Impact Partnerships & Foundations
Building Scalable Diagnostic Access, Local Manufacturing, and Health Equity Across Africa
Millions across Africa lack access to early diagnosis — the doorway to treatment, prevention, and life-saving care. At 360Disruption, we are committed to changing that by helping nations build self-sufficient diagnostic ecosystems, powered by saliva-based molecular and protein testing technologies from Oasis Diagnostics.
We work with governments, global foundations, development partners, and innovators to bring diagnostics directly into communities — while building local manufacturing capacity that creates jobs, strengthens economies, and reduces dependency on imported medical consumables.
This is not consultancy.
This is execution for national impact.
Our Mission
To democratize early disease detection across Africa through scalable saliva diagnostics, telehealth integration, and local manufacturing powered by FDI — ensuring every community, from major cities to remote villages, gains access to timely, affordable, and non-invasive testing.
What We Do With Foundations
1. Expand Access to Diagnostics
We deploy saliva-based molecular and protein testing technologies in underserved regions where traditional blood-based diagnostics are difficult or impossible to access.
2. Build Local Manufacturing Hubs
Working with free zones and ministries, we establish assembly and production sites for diagnostic devices, creating skilled jobs and keeping healthcare spending inside the country.
3. Strengthen Public Health Systems
We support Ministries of Health with logistics, screening strategies, data systems, community health worker deployment, and scalable national rollouts.
4. Integrate Telehealth & Digital Care
With partners like Oludent Health International, we connect diagnostics to real medical follow-up — consultations, referrals, and care pathways.
5. Enable Sustainable FDI Models
We align health impact with economic development by structuring foreign direct investment to support local industry growth, job creation, and technology transfer.
Why Saliva Diagnostics?
Because it solves real constraints:
No needles
No doctors required
No cold chain
Minimal training
Perfect for rural and decentralized care
Supports PCR-level molecular testing & protein biomarkers
Scalable to millions
It is the first realistic diagnostic platform built for widespread population access in African environments.
Current Priority Countries
🇨🇩 Democratic Republic of Congo
Developing a nationwide diagnostic access and local assembly framework.
🇿🇲 Zambia
Rolling out community-level saliva testing and telehealth integration.
🇳🇬 Nigeria
Africa’s Greatest Untapped Diagnostic Market
🇬🇭 Ghana
A Stable, High-Innovation Environment for Rapid Rollout
🇸🇩 Sudan
Positioned for funding to combine diagnostics with renewable-energy-powered delivery.
Additional engagements: Ethiopia, Kenya, Ghana, Rwanda, Tanzania.
Our Model Aligns With Global Funders’ Priorities
✔ Universal Health Coverage
✔ Women’s Health & Maternal Care
✔ Early Detection & Prevention
✔ Health Equity in Rural Communities
✔ Climate-Smart, Low-Resource Diagnostics
✔ Local Manufacturing & Job Creation
✔ Digital Health & Telemedicine
✔ System-Level Strengthening
✔ Technology Transfer to Africa
✔ Economic Empowerment Through FDI
Foundations we align strongly with include:
The Story of How Three Very Different People Aligned for One Mission
Sometimes the most important missions don’t begin with a plan —
they begin with people.
A scientist in the United States, quietly perfecting saliva-based molecular diagnostics for nearly two decades.
Focused, meticulous, visionary — but frustrated that cutting-edge technology often never reaches the people who need it most.
A clinician and digital-health pioneer, building telehealth and diagnostic workflows that could reach patients anywhere.
A problem-solver, a systems builder — someone who has seen too many preventable conditions escalate simply because the right test was not available in time.
And a cross-continental strategist, moving between the UAE, Africa, and the United States.
An ecosystem builder determined to solve structural problems — not with theory, but with execution, partnerships, FDI pathways, and national-scale deployment.
Three people.
Three worlds.
Three disciplines that rarely meet.
Yet somehow, all three collided around a single truth:
Africa cannot rise without diagnostics.
Not when the continent carries 24% of the global disease burden but has 1% of diagnostic capacity.
Not when preventable diseases go undetected simply because testing is out of reach.
They realized something else:
A scientist alone cannot fix this.
A clinician alone cannot fix this.
A strategist alone cannot fix this.
But together? They can build a continental pathway.
And that is how Oasis Diagnostics, Oludent Health, and 360Disruption became one aligned engine —
technology + clinical workflow + execution.
Three completely different people,
from different continents,
with different backgrounds,
who saw the same problem
and chose to do something about it.
And This Story Is Still Being Written.
Because if three people can find each other —
across oceans, cultures, industries, and time zones —
then more can join the mission.
360Uncover is not a closed group.
It is a growing movement.
We are actively looking for:
-
Diagnostics innovators
-
Medical device creators
-
AI + healthtech pioneers
-
Local African partners
-
Ministries and national programs
-
NGOs and philanthropic organizations
-
Investors who want measurable, national-scale impact
If you share the belief that every person deserves access to early detection,
then you belong in this story.
Because Africa doesn’t need another pilot.
Africa needs a platform.
A coalition.
A continental execution engine.
And that begins with people —
just like the three who started this journey.
Leadership
Anjo De Heus —
Founder & Chief Strategist, 360Disruption
Anjo De Heus is a U.S./UAE-based entrepreneur, strategist, and ecosystem architect with a lifelong commitment to turning innovation into impact for communities that have historically been left behind. As the founder of 360Disruption, he leads one of the very few organizations that combine global innovation sourcing, government-level execution, and sustainable commercialization models designed specifically for emerging markets.
Throughout his 30-year career, Anjo has built, scaled, and guided ventures across the United States, the Gulf region, and Africa — uniting ideas, capital, and partnerships into systems that create lasting social and economic value. His work centers on bridging international healthtech, biotech, AI, and diagnostics innovators with regions where early detection, access to care, and preventive medicine can create immediate and measurable impact.
Anjo’s experience spans entrepreneurship, corporate strategy, and technology commercialization. Earlier in his career, he played a pivotal role in scaling multiple technology ventures — including one that grew to more than $80 million in annual revenue through strategic partnerships with SAP and HP. He later founded and co-founded successful initiatives in blockchain, AI-driven platforms, smart city technologies, and global venture incubation.
Today, he is recognized for his unique ability to work simultaneously with U.S. innovators, GCC regulators and economic development authorities, and African government leaders, acting as a translator, dealmaker, and execution partner across all three worlds. His approach ensures that life-changing technologies move beyond PowerPoints and pilot projects — into real deployment on the ground.
He currently leads diagnostic, telehealth, and population-health initiatives across Zambia, the Democratic Republic of Congo, Ethiopia, and other African countries, while maintaining close strategic engagement with government partners in the UAE where 360Disruption is based. His emphasis on FDI-driven development, local manufacturing, and capacity building has positioned 360Disruption as one of the most practical and credible platforms for health innovation scaling across Africa and the Gulf.
Anjo is also a mentor to emerging entrepreneurs, advocating for a model of innovation that prioritizes responsibility, dignity, and long-term nation-building over short-term transactional wins.
Dr. Paul D. Slowey — Founder & CEO, Oasis Diagnostics
Dr. Paul D. Slowey is a globally recognized leader in oral-fluid diagnostics and non-invasive testing — with over 35 years of experience in clinical diagnostics, pharmaceutical development, and diagnostic innovation.
As Founder & CEO of Oasis Diagnostics Corporation, Paul pioneered saliva-based diagnostic platforms that have redefined disease detection globally. His work spans molecular diagnostics (DNA/RNA), protein-based assays, immunoassays, and multiplex biomarker detection, unlocking the full potential of saliva — from infectious disease screening to oncology biomarkers, hormonal panels, and population health surveillance.
Paul earned his PhD in Organic Chemistry from the Newcastle University (UK). Over his career, he has held senior roles in leading diagnostic and pharmaceutical firms — including work in international sales, R&D, and operations — before founding Oasis Diagnostics to commercialize his innovation in oral-fluid diagnostics.
Under his leadership, Oasis Diagnostics has produced multiple patented technologies, including collection devices suited for all ages and species (infants to large animals), purification systems for high-quality nucleic acid and protein samples, and portable “point-of-care” kits. These devices are globally deployed in research labs, clinical trials, public-health screening programs, and field diagnostics — especially for hard-to-reach populations.
Significantly, during the COVID-19 pandemic, Oasis Diagnostics scaled production dramatically — winning contracts (e.g. via the National Institutes of Health, USA) under the RADx program to supply millions of saliva collection kits worldwide.
As the scientific backbone of our Africa diagnostics initiative, Paul brings:
-
rigorous assay development expertise,
-
proven global manufacturing and distribution track record,
-
regulatory experience,
-
and a deep commitment to accessible, non-invasive diagnostics for underserved communities.
With his leadership, Oasis Diagnostics provides the technical foundation, while 360Disruption provides the strategic framework, and local partners handle implementation — creating a full-stack solution ready for scale.
Dr. Oluwadara Oluwadayo — Clinical Strategist & Africa Health Systems Specialist
Dr. Oluwadara brings critical on-the-ground African health expertise, bridging the gap between advanced diagnostic technologies and real-world healthcare delivery in low-resource environments.
A seasoned clinician, technologist, and founder of Oludent Health International, he specializes in implementing scalable digital health and telemedicine systems across Africa. His work focuses on:
-
frontline clinical deployment
-
maternal and women’s health access
-
community diagnostic networks
-
digital triage and referral pathways
-
rural and peri-urban health system improvement
Having worked extensively with hospitals, ministries, and private-sector health providers across the continent, Dr. Oluwadara ensures that our diagnostic programs translate into practical, culturally aligned, clinically validated solutions that work for African communities.
He is instrumental in shaping our telehealth integration, workforce training, and real-world care pathways — ensuring that diagnostics do not end at the test, but lead to treatment, referral, and long-term health outcomes.
We Are Seeking Collaborative Funding Partners
If you are a foundation, development organization, or government entity committed to health equity, early detection, and economic resilience across Africa, we invite you to partner with us.
Together, we can build a future where diagnostics are accessible to everyone — and where African nations manufacture their own health technologies.
👉 Contact us to explore partnership opportunities.
Email: impact@360disruption.com
360UNCOVER — Accelerating Diagnostic Sovereignty Across Africa
An initiative by 360Disruption F.Z.E., in collaboration with
Oasis Diagnostics Corporation (USA) and Oludent Health International (USA/UAE).
We build scalable diagnostic ecosystems, national screening programs, and sovereign health capabilities for African nations.
UAE | USA | Africa
info@360disruption.com
360Disruption.com | 360Uncover.com
© 2026 360Disruption F.Z.E. All rights reserved.
Trusted by Leaders Across Regions
360Disruption collaborates with ministries, free zones, innovation hubs, and senior government officials across the GCC and Africa.